$IMGN News Article - ImmunoGen Announces a Global, Multi-Target License and Option Agreement with Vertex for the Use of ImmunoGen's ADC Technology in the Development of Novel Targeted Conditioning Agents
https://marketwirenews.com/news-releases/immu...26601.html